The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: A single center experience from Turkey-Reference-Cited by-同舟云学术

The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: A single center experience from Turkey

Published:2013-06 Issue:3 Volume:48 Page:315-320
ISSN:1473-0502
Container-title:Transfusion and Apheresis Science
language:en
Short-container-title:Transfusion and Apheresis Science

Author:

Sivgin Serdar,Karakus Esen,Kaynar Leylagul,Kurnaz Fatih,Pala Cigdem,Keklik Muzaffer,Zararsiz Gokmen,Solmaz Musa,Eser Bulent,Cetin Mustafa,Unal Ali

Publisher

Elsevier BV

Subject

Hematology

Reference26 articles.

1. Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastoma;Handgretinger;Bone Marrow Transplant,2002

2. The feasibility of neoadjuvant high-dose chemotherapy and autologous blood stem cell transplantation in patients with nonmetastatic high grade localized osteosarcoma;Arpaci;Cancer,2005

3. Advances in mobilization for the optimization of autologous stem cell transplantation;Vose;Leuk Lymphoma,2009

4. 2006 Update of recommendations for the use of white blood cell growth factors: an evidence based clinical practice guideline;Smith;J Clin Oncol,2006

5. Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin’s lymphoma;Pettengell;J Clin Oncol,1996

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122);Cancer Medicine;2023-03-23

2. Lenograstim versus filgrastim in mobilization before autologous hematopoietic stem cell transplantation in patients with multiple myeloma and lymphoma - Single center experience;Transfusion and Apheresis Science;2021-08

3. Can biosimilar products be interchangeable? Pharmaceutical perspective in the implementation of biosimilars in oncology;Journal of Oncology Pharmacy Practice;2021-05-14

4. Evaluation of adverse events associated with filgrastim originator and biosimilar using a spontaneous reporting system database;PHARMAZIE;2020

5. Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries;Bone Marrow Transplantation;2019-09-04